The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study

BACKGROUND: Thrombosis with thrombocytopenia syndrome (TTS) associated with viral vector COVID-19 vaccines, including ChAdOx1-S (AstraZeneca AZD1222) vaccine, can result in significant morbidity and mortality. We report the clinicopathological features of TTS following ChAdOx1-S vaccination and summ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Huyen A., Deng, Lucy, Wood, Nicholas, Choi, Philip, Singleton, Sally, Clarke, Lisa, Khanlari, Sarah, Maitland-Scott, Isis, Bird, Robert, Brown, Scott, Manoharan, Bavahuna, Tan, Chee Wee, Gold, Michael, Hissaria, Pravin, Melody, Shannon, Chunilal S, Sanjeev D., Buttery, Jim, Clothier, Hazel, Crawford, Nigel W., Phuong, Linny, Pepperell, Dominic, Effler, Paul, Parker, Claire, Carter, Nicola, Macartney, Kristine, McStea, Megan, Miller, Todd, Nissen, Michael, Larter, Claire, Kay, Elspeth, Chen, Vivien M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494168/
https://www.ncbi.nlm.nih.gov/pubmed/37701717
http://dx.doi.org/10.1016/j.lanwpc.2023.100894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494168/
https://www.ncbi.nlm.nih.gov/pubmed/37701717
http://dx.doi.org/10.1016/j.lanwpc.2023.100894

Ejemplares similares